Genzyme
Genzyme MS drug shines in head-to-head trial with Rebif
April 18, 2011Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis
Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …
Setback on road to recovery for Genzyme’s Allston facility
March 28, 2011Manufacturing and Production Genzyme
Genzyme has been forced to discard one lot of its Fabry disease treatment Fabrazyme (agalsidase beta) manufactured at its troubled …
Sanofi seals Genzyme deal for $20 billion
February 16, 2011Research and Development, Sales and Marketing Genzyme, Sanofi
Sanofi-Aventis has finally agreed a deal to buy Genzyme for $20.1 billion after eight months of wrangling with the US …
Genzyme to divest pharma intermediates business
February 8, 2011Manufacturing and Production Cerezyme, Corden Pharma Switzerland, Corden Pharma group, Genzyme, International Chemical Investors Group, Sekisui Chemical Co, imiglucerase
Genzyme has agreed to sell off its pharmaceutical intermediates business to International Chemical Investors Group, a holding company which has …
Sanofi – Genzyme deal edges closer
February 1, 2011Sales and Marketing Genzyme, Lemtrada, Sanofi
Sanofi-Aventis has entered into a confidentiality agreement with Genzyme to discuss the prospects of Lemtrada, which suggests a deal could …
Genzyme plans new Belgium facility
January 25, 2011Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa
US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …
Sanofi ‘considering’ raising Genzyme offer
January 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions
Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …
Sanofi’s Genzyme takeover bid focuses on Campath
January 10, 2011Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition
Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
Sanofi extends Genzyme share deal deadline
December 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
Pfizer submits Gaucher drug to EMA
November 29, 2010Sales and Marketing Cerezyme, EMA, Gaucher disease, Genzyme, Pfizer, Protalix BioTherapeutics, Shire, Vpriv, taliglucerase alfa
Pfizer and partner Protalix BioTherapeutics have submitted a marketing application to European regulator the EMA for their Gaucher disease candidate …
Roche to develop diagnostic tools for Tarceva
November 23, 2010Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic
Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …
Genzyme courting ‘white knight’ bid from Takeda
November 18, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers
Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
Genzyme again snubs suitor Sanofi
November 10, 2010Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance
Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …
Digital Pharma: Genzyme’s augmented reality heart
October 12, 2010Medical Communications Digital Pharma blog, Genzyme, augmented reality
Genzyme Europe has launched a new website that allows users to take a peak inside their own heart, or so …
Sanofi makes hostile offer for Genzyme
October 4, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …
